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Abstract
Robotic and automation technologies have played a huge role in in vitro biological science, having
proved critical for scientific endeavors such as genome sequencing and high-throughput screening.
Robotic and automation strategies are beginning to play a greater role in in vivo and in situ
sciences, especially when it comes to the difficult in vivo experiments required for understanding
the neural mechanisms of behavior and disease. In this perspective, we discuss the prospects for
robotics and automation to impact neuroscientific and intact-system biology fields. We discuss
how robotic innovations might be created to open up new frontiers in basic and applied
neuroscience, and present a concrete example with our recent automation of in vivo whole cell
patch clamp electrophysiology of neurons in the living mouse brain.
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Introduction: automation in biology
Robotics has played a major role in the advancement of biological research in the past few
decades. Semi-autonomous machines integrate hardware, wetware, and software from
precision engineered or microfabricated parts to nimbly load, manipulate, and measure
thousands to millions of biological samples simultaneously, more rapidly, more sensitively,
more accurately, or in a more repeatable manner than manual approaches. Their applications
span the research space from automated phenotyping to high-throughput screening to
imaging to genome sequencing. Examples abound for how these tools have opened the door
to essential, comprehensive biological studies. In the race to sequence the human genome in
the 1990s, robots capable of high-throughput analysis of microliter volumes of liquid were
developed and deployed massively (Fig. 1). As just a few examples, high-throughput
microfluidics1, 2 can now be used to perform nearly 10,000 independent real time PCR
reactions for genotyping3 and transcriptome profiling applications.4–8 Fluid handling robots
have revolutionized synthetic biology by enabling the efficient, rapid transfer of reagents
Address for correspondence: Craig R. Forest, Georgia Institute of Technology, 813 Ferst Dr., Room 411, Atlanta, GA 30332.
cforest@gatech.edu.
Conflicts of interest
C.R.F., E.S.B., and S.B.K. are co-inventors on a patent owned by MIT and Georgia Institute of Technology. C.R.F. and S.B.K. are
financially affiliated with Neuromatic Devices, which is seeking to manufacture and sell autopatching robots.
NIH Public Access
Author Manuscript
Ann N Y Acad Sci. Author manuscript; available in PMC 2014 December 01.
Published in final edited form as:













from one set of plates to another.9,10 Automated plate readers and microscopy methods
enable time-lapse imaging of physiological changes in cultured cells, and in vitro patch
clamping enables automated electrophysiology in cell lines.11–15 These innovations are very
widely used, and sometimes ubiquitous, in major research institutions and industrial settings
such as in pharmaceutical and biotechnology companies.
Value and principles of in vivo and in situ automation
Despite this progress and the pervasive presence of automation in molecular biology today,
there remain many tedious and repetitive manual tasks, as well as more complex tasks which
defy straightforward automation, and that are more akin to art forms than scientific
processes. Often they have not been systematically analyzed but are passed down through
generations of researchers as best practices. This practice sometimes limits use to a few
highly-skilled laboratories, especially when living organs or organisms are involved, as in in
vivo neuroscience experiments. This frontier represents an opportunity because automation
would not only make things simpler, increasing the rate of adoption and progress of specific
approaches, but broadens the number of individuals and laboratories that can contribute
innovations, since they no longer have to improve an art form, but rather can iteratively
improve the protocols performed by a robotic agent. Further, higher throughput automation
can enable scaling of the number of parallel samples being analyzed, or the number of
analyses being performed per sample, or the sampling rate. It can also lead to increased
standardization of procedures across laboratories, important for improving the ability of
different parts of the literature to be integrated, and for results from different groups to be
compared.
In many cases, increasing the number of observations that can be made in parallel is
important not only for augmenting the amount of data that can be collected, but can also
open up fundamentally new kinds of investigation. For example, making many simultaneous
observations on different parts of an intact system – an organ, such as the brain, or even an
entire organism – might reveal correlated, and perhaps coordinated, physiological processes
taking place in different parts of the system, which would never be revealed by investigation
of single sites one at a time. As another example, the ability to perform tasks often done in
vitro – from pharmacological assessment to biochemical analysis – in the living organism,
would enable detailed understanding of how specific processes of basic or applied scientific
interest take place, in the full context of an intact organism, including its baseline activity,
awake or behaving state-dependent modulation, or disease states.
Rethinking in vivo procedures for automation
In order to automate a complex in vivo or in situ procedure, it is very important to
understand how humans perform the procedure, not only analyzing the procedure at face
value but also delving deeply into the parameters that govern success or failure of the
procedure. This often means that the engineer seeking to automate a procedure must not
simply take requests from biologists, simply attempting to automate their stated methods,
but instead must herself master the procedure, so that it is possible for the engineer to
understand the best possible way for the procedure to be automated. Very often, the way that
a human performs will not necessarily be the easiest way to perform the task in an
automated fashion. Humans often use complex sets of cues—visual and auditory, for
example—to perform in vivo experiments. But for automation, it may be important to rely
upon more straightforward and less complex modalities, such as electrical impedance
(which can nevertheless indicate important properties of a tissue that a robotic device is
exploring). In addition, humans conduct in vivo experiments with their very-high-degree-of-
freedom hands and synergistic muscular systems, but the range of inexpensive actuators that
Kodandaramaiah et al. Page 2













are reliable and inexpensive enough to become commonly used in messy and complex
biology lab environments, may require a greater reliance on good software and rethinking of
the procedure to minimize the number of expensive actuators required, or even a rethinking
of the modality of actuation (e.g., replacing a complex robot arm with a scanning laser
beam). Below, we explore these two arenas of endeavor – how to find the most easily
automated methodology for performing a complex in vivo procedure, and how to devise the
simplest and most robust modality of actuation and style of robot –in the context of an area
that we have recently pioneered, the automation of intracellular neural recording in the
living brain.
In vivo neuroscience and past automation efforts
The vertebrate brain is a complex organ consisting of billions of neurons,16 each of which is
interconnected with thousands of other neurons through synapses.17 Each neuron receives
information via synaptic transmission, computes an electrical signal within it, and transmits
information to downstream neurons. They express different sets of genes,18 have myriad
morphologies, and undergo plasticity in different ways during performance of cognitive
tasks and learning. Thus, one of the fundamental challenges for neuroscientists has been the
difficulty of linking the knowledge we have on cellular level phenomena, such as synaptic
transmission, often gained by manual in vitro experimental preparations; to emergent
properties of the intact living system such as learning and memory. Technologies including
electrical neural recording, the generation of transgenic animals, the use of optogenetic
neural control,19,20 optics to image intact neural systems, and cell- and circuit-resolution
molecular and biochemical analyses, are all important. However, many of these techniques
are art forms, requiring extensive effort to learn, typically time consuming to perform, and
lacking in scale, without standardization across groups, and with innovations typically
driven in different directions by different laboratories. Arguably, many of these areas are
ripe for robotic innovation.
In these in vivo and in situ (i.e., intact tissue) spaces of endeavor, robotics and automation
have already begun to make inroads. The use of laser capture microdissection to
automatically isolate cellular contents from tissues is enabling new kinds of systems
biology,21 and also supporting a diversity of histopathological studies. Microfluidic devices
for whole-organism imaging and sorting are having great impact on the study of organisms,
such as C. elegans,22–25 Drosophila,26 and zebrafish,27 enabling rapid imaging, sorting, and
adaptive control of these organisms for both advancement of basic biology as well as
accelerated pharmacological screening. Another area where robotics has played a crucial
role for in situ analysis is in the field of intact tissue imaging. Automated serial block-face
scanning electron microscopy, as well as automated histology systems,28 have driven
progress in the nascent field of connectomics.29 High-throughput, automated in situ
hybridization along with automated imaging platforms were indispensible for charting the
mouse brain gene expression maps of the Allen Brain Atlas.30 Intact tissue analysis has
benefited from automated sectioning, in situ hybridization, and imaging of tissue
samples.28,31–33 Motorized devices have been devised to support the lowering of tetrodes
into the living rat brain,34 and to enable automated stabilization of extracellular recording
electrodes for maintaining optimal recording quality.35 In addition, automated electrode
recording stabilization techniques have been explored for stabilizing sharp recordings
against brain movement in awake, behaving zebra finches.36 We have recently explored the
automation of multisite viral injection, using precisely-timed fluidic delivery of viruses to
three-dimensional structures in the brain, in an easily user-customizable fashion37 (a process
that one can imagine would easily be extended to stem cell or pharmacological injection in
many sites at once). Microfabricated strategies for adaptively moving many extracellular
microelectrodes could lead to improvements in the development of reliable and stable
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interfaces with single neurons, important for basic neurophysiological studies and emerging
cortical prosthetic technologies.38 Beyond the analysis of live animals and preserved animal
and human tissues, robotic actuators are now routinely used in clinical settings to enhance
the ability of humans to perform complex surgical procedures.39 For example, the Amadeus
and Da Vinci robotic are used to perform minimally invasive laproscopic procedures, as
well as robot-assisted telesurgery.40 Robots are increasingly playing a role in even delicate
neurosurgeries, as well as in cardiac surgery,41 and being incorporated into operating room
systems that enable noninvasive visualization as well (e.g., the neuroArm, a MRI-guided
robotic actuator42). These advances illustrate the broad and deep impacts already stemming
from automation technologies on the study or manipulation of living or intact biological
systems in basic biology and medicine.
Case study: in vivo patch clamp neural recording
To explore in depth a specific avenue of in vivo robotic engineering, we discuss a
technology we recently developed that assists in the mechanistic understanding of how
cellular level activities of neuronal networks give rise to higher level cognitive abilities, and
how they go awry in brain disorders. To study cellular level activity, ideally one would be
able to observe electrical activities in neurons with intracellular, synaptic resolution, and
ideally in a fashion capable of linking this physiological information to the genetic and
morphological information associated with the cellular identity. Such integrated network-
wide studies will require new technologies that can access these single cells efficiently and
in way that is able to be scaled. One method for doing this, which works even in vivo, is
whole-cell patch clamp neural recording. In this technique, a glass micropipette establishes
an electrical and molecular connection to the insides of an individual cell embedded in intact
tissue. Invented in 1981,43 and winning Neher and Sakmann the Nobel Prize in 1991,
whole-cell patch clamping enables recording of the electrical activity of neurons in vivo that
exhibit signal quality and temporal fidelity sufficient to report synaptic and ion channel–
mediated subthreshold events of importance for understanding not only how neurons
compute during behavior, but how their physiology changes in disease states or in response
to drug administration. Further, it enables dye infusion for morphological visualization, and
extraction of cell contents for transcriptomic analysis.44–46 Potentially, in vivo patch
clamping could have clinical impact, being used in neurosurgical settings to do integrative
measurements on single cells in, for example, the epileptic brain. This technique could also
be used to analyze biopsy samples (e.g., from tumors) or from surgical resections of the
brain, at single-cell resolution, potentially revealing tissue heterogeneity and thus new
principles of personalized medicine. Such studies that link molecular, cellular, and
anatomical properties of individual cells to their behavioral or disease circuit context are
difficult in vitro.
Despite these compelling opportunities, in vivo patching requires skill, and the hardware
required is specialized and expensive. Thus, in vivo patching has been utilized by a
relatively small number of labs, and is usually regarded as a difficult technique, performed
manually by highly skilled operators trained by masters, in the anesthetized brain, and in
very limited applications in the awake brain.47–52 Accordingly, we considered it as an ideal
example of a neuroscience technique to automate.
We began by analyzing what humans do while they perform in vivo patch clamping. This
required examination of humans in the laboratory as they performed patch clamping, to
analyze the actual methodology they used to perform this task. Importantly, we then
examined the physics and mechanics of what was being done, in order to isolate parameters
most amenable to automation (e.g., focusing on a time-series electrical impedance analysis
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for our automation, rather than relying on visual detection of stereotyped patterns of
electrical signal, such as heartbeat-rhythm modulation of the recording).
By doing this analysis, we discovered that single cells could be accurately detected by
analyzing the temporal sequence of micropipette impedance changes as the micropipette is
lowered into the brain (Fig. 2A), looking for particular signatures of temporal change in
pipette resistance. Building from this observation, we found that blind in vivo whole-cell
patching of neurons, in which micropipettes were lowered until a cell is detected and then
recorded, could be reduced to a reliable algorithm, in which cells are detected with > 90%
yield, and the whole-cell state established in 40–60% of detected cells,53 with the yields for
whole-cell state establishment exceeding 60–70% at the beginning of a session when the
brain was intact, and declining to 30–50% over time as multiple brain penetrations occurred.
The next step was to devise the simplest robotic invention that could perform this algorithm.
The algorithm could be realized by a simple robot (Figs. 2B and 2C), which actuates a set of
motors and valves rapidly upon recognition of specific temporal sequences of micropipette
impedance changes, achieving whole-cell patch clamp recordings in 3–7 min each in the
anesthetized and awake mouse brain. The robot we designed is relatively inexpensive, is
made out of easily accessible, commercially available parts, and thus can easily be appended
to an existing patch clamp electrophysiology rig, by adding a few valves, a computer-
controlled linear motor, and a digital interface board for analyzing micropipette impedance
changes, and actuating the motor and valves.
The robot can obtain very high quality intracellular electrical recordings of neurons, even
millimeters deep, in living mouse brain (Fig. 2D), and works in multiple brain regions,
suggesting that our algorithm has a degree of generality. The fact that a robot performs it
makes exploration of new algorithm variants a simple task. We are starting to explore the
capabilities of our robot in the awake rodent brain54 and its compatibility with optogenetics,
which could enable on-the-fly cell type identification.54 We are currently aiming to derive
new algorithms for procedures which humans do not perform at all, such as the simultaneous
patch clamp of many neurons at once,55,56 which requires study of how multiple
independent patch pipettes might interact in the dense tissue of the living brain.
Potential pitfalls in in vivo robotics, and how they might be addressed
In vivo neuroscience is a combination of multiple experimental procedures, often required to
be performed sequentially. For fully realizing the potential of robotics, it is not necessary
just to automate one aspect of the experimental workflow, but develop platforms for
automating upstream and downstream processes as well. These systems will need to be built
modularly, so as to be easily integrated into the work flow and be reconfigurable to be
broadly applicable to many experimental protocols, while taking into consideration inherent
variability in the in vivo biological milieu. For example, in the case study of our automated
patch clamp robot, true high throughput will only be achieved if we can scale the control
algorithms and the hardware to control large arrays of recording electrodes in the fashion of
tetrodes and silicon probes, and additionally automated accessory tasks, such as animal
surgery, the fabrication of electrodes, the swapping in of fresh electrodes after each
experiment, and real-time logging and analyzing of the acquired data. In particular, as
automation of other procedures such as animal neurosurgeries emerge, ethical considerations
will be important in the engineering as well – for example, if the robot were to fail, it should
fail in a safe mode that does not jeopardize the health or well-being of the animal subject.
Also, if a robot must halt a procedure that is partially completed, it must be able to either
bring the experimental episode to a conclusion in a way that preserves animal welfare, or
promptly alert a nearby human attendant to intervene. One possibility is that in vivo
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automation will enable scientists to perform experiments much more efficiently and
effectively than before, enabling higher success rates in animal experimentation, and more
data acquired per animal used, important for ethical, scientific, and financial reasons.
Endeavors in in vivo robotics may benefit from multi-lab collaborations that collectively
contain deep domain knowledge in multiple aspects of neuroscience as well as multiple
aspects of the engineering. These efforts will require significant investments for innovating
technologies and scaling up infrastructure as technologies mature. Recent work by the Allen
Institute for Brain Science,30 the emerging European Human Brain Project,57 and the
excitement generated by recent proposals in the United States, such as the Brain Activity
Map (BAM) initiative,58–60 suggest that the time may be ripe for the automation and scaling
up of neuroscientific procedures.
This also brings into discussion the role that will have to be played by entities outside of
academia. Although many entities have launched to foster the distribution of DNA (e.g.,
http://addgene.org) and viruses (e.g., various university viral core facilities), there are no
comparable methodologies for distributing robots. Entrepreneurial and commercialization
endeavors may be the de facto path, but open access and open source models may well be as
important (if not more important, in the early days when many groups may seek to
customize robots for specific kinds of application). Ensuring broad dissemination means
increasing usability (i.e., through the creation of simple yet powerful user interfaces,
working to make devices fault tolerant, and connecting devices to existing laboratory
hardware), while working to keep costs and prices down to maximize impact. To enable
rapid dissemination to the scientific community, it may be important to pursue such
simplification and robustness activities in commercial entities, while simultaneously
enabling immediate free access to non-profit and academic researchers who seek to try it out
right away (e.g., by making all parts lists, computer-aided design (CAD) drawings, and
software available on the internet, or even by setting up core facilities within universities to
manufacture components for their communities)).
There may well be great demand in the future for innovation in the field of in vivo robotics,
particularly in neuroscience. In vivo stem cell biology, in vivo imaging (especially over long
periods of time), stereotactic surgery (to insert drugs and devices, or to make
measurements), and ex vivo analyses of tissues, are all in need of automation that powerfully
enables everyday art forms to become simple and inexpensive, and to later enable these
tasks to be performed at such scales, and in such integrated fashions, as to reveal new kinds
of integrated patterns and principles of biological operation. As such in vivo automation
tools find uses driven by biological discovery, it is likely that they, like in vitro automation
tools, will find clinical uses, perhaps in contexts such as diagnostics, neurosurgery, or other
fields.
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One of many rows of ABI 3730xl automated DNA Analyzers for shotgun sequencing of the
human genome in months (30 billion bp/year) in 2005. (Courtesy: Steve Jurvetson)
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The autopatcher: a robot for in vivo patch clamping. (Ai) The four stages of the automated in
vivo patch algorithm, discovered through iterative exploration of the parameters governing
successful patch clamping: regional pipette localization, in which the pipette is lowered to a
target zone in the brain; neuron hunting, in which the pipette is advanced until a neuron is
detected via a change in pipette resistance; gigaseal formation, in which a gigaseal state is
achieved (if cell-attached patching is desired, the algorithm can end here); break-in, in which
the whole cell state is achieved. (Aii) Yields and durations of each of the four stages, when
executed by the robot shown in B, running the autopatching algorithm in the living mouse
brain, aiming for targets in cortex and hippocampus. (B) Schematic of a simple robotic
system capable of performing the autopatching algorithm. The system consists of a
conventional in vivo patch setup (i.e., pipette, headstage, three axis linear actuator, patch
amplifier plus computer interface board, and computer), equipped with a few additional
modules: a programmable linear motor (to move the pipette up and down in a temporally
precise fashion), a controllable bank of pneumatic valves for pressure control, and a
secondary computer interface board to enable closed-loop control of the motor based upon
sequences of pipette resistance measurements. (C) Photograph of the setup, focusing on
three axis linear actuator (with additional programmable linear motor) and the holder for
head fixing the mouse. (D) Current clamp traces during current injection for a cortical
neuron for which whole-cell state was established via autopatcher. (E) Current clamp traces
during current injection for a hippocampal neuron for which whole-cell state was established
via autopatcher. Adapted, with permission, from Kodandaramaiah et al.53
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